**CONFIDENTIAL - DRAFT - NOT FOR DISTRIBUTION**

==========================================================
                    TERM SHEET
                 SERIES B FINANCING
                    NEXUSAI, INC.
==========================================================

This term sheet summarizes the principal terms of a proposed
Series B Preferred Stock financing of NexusAI, Inc. (the "Company").
This term sheet is for discussion purposes only and is not binding.

----------------------------------------------------------
                    OFFERING TERMS
----------------------------------------------------------

Issuer:                 NexusAI, Inc., a Delaware corporation

Security:               Series B Preferred Stock

Amount:                 $18,000,000 (may increase to $22,000,000
                        with follow-on participation)

Pre-Money Valuation:    $65,000,000

Post-Money Valuation:   $83,000,000 (assuming $18M raise)

Price Per Share:        $8.42 (subject to adjustment)

Lead Investor:          [REDACTED] Ventures

Participating:          - [REDACTED] Capital (existing, pro-rata)
                        - [REDACTED] Partners (new)

----------------------------------------------------------
                    KEY TERMS
----------------------------------------------------------

Board Composition:      Five (5) directors:
                        - Two (2) designated by Common
                        - Two (2) designated by Preferred
                        - One (1) independent, mutually agreed

Liquidation            1x non-participating preferred
Preference:            

Anti-Dilution:         Broad-based weighted average

Protective             Consent required for:
Provisions:            - Changes to authorized shares
                       - Dividends on Common
                       - Acquisition, merger, or sale
                       - Debt exceeding $500,000
                       - Changes to Board size

Drag-Along:            Standard (majority of Preferred + Common)

Right of First         Pro-rata rights for investors holding
Refusal:               >2% of Series B

Information            Quarterly financials, annual audited
Rights:                statements, annual budget

----------------------------------------------------------
                    USE OF PROCEEDS
----------------------------------------------------------

The Company intends to use the proceeds as follows:

- Engineering & Product (50%):      $9,000,000
  - Hire 15 additional engineers
  - Accelerate product roadmap
  - EU infrastructure deployment

- Sales & Marketing (30%):          $5,400,000
  - Expand sales team to 18
  - International market entry (UK, Germany)
  - Brand awareness campaigns

- Customer Success (12%):           $2,160,000
  - Scale CS team for enterprise support
  - Implementation services capacity

- G&A (8%):                         $1,440,000
  - Finance, HR, legal infrastructure
  - SOC 2 / compliance requirements

----------------------------------------------------------
                    MILESTONES
----------------------------------------------------------

The Company has represented that this financing will enable
achievement of the following milestones within 24 months:

- ARR:                  $32,000,000 (from current $8.6M)
- Customers:            75+ enterprise accounts
- Gross Margin:         >82%
- Net Revenue Retention: >115%
- Geographic:           UK and Germany market presence

----------------------------------------------------------
                    CONDITIONS PRECEDENT
----------------------------------------------------------

- Completion of due diligence satisfactory to Lead Investor
- No material adverse change in business
- Satisfactory legal documentation
- Board approval

----------------------------------------------------------
                    TIMING
----------------------------------------------------------

Due Diligence Period:   January 6-31, 2026
Target Signing:         February 15, 2026
Target Closing:         March 1, 2026

----------------------------------------------------------
                    CONFIDENTIALITY
----------------------------------------------------------

This term sheet and its contents are confidential and may
not be disclosed to any third party without prior written
consent of the Lead Investor.

----------------------------------------------------------

ACKNOWLEDGED AND AGREED (for discussion purposes only):

NexusAI, Inc.

_________________________    Date: ____________
Maya Rodriguez, CEO


[LEAD INVESTOR]

_________________________    Date: ____________
[Name], General Partner

==========================================================
          DRAFT v3 - January 2, 2026 - CONFIDENTIAL
==========================================================
